Clinical Scorecard: Exploring the Role of Laminar Functional MRI in Enhancing Insights into Human Epilepsy
At a Glance
Category
Detail
Condition
Epilepsy, including drug-resistant and focal/generalized seizures
Key Mechanisms
Dysfunctional neural networks involving nano-scale ion channel/receptor abnormalities, micro-scale cortical layer microcircuits, and macro-scale brain network activity
Target Population
Patients with epilepsy, including those with drug-resistant epilepsy
Care Setting
Neurology clinics, epilepsy centers, and surgical planning settings
Key Highlights
Drug-resistant epilepsy affects 25%–30% of patients despite decades of treatment development.
Antiseizure medications target nano-scale structures but are measured at macro-scale, creating a disconnect in understanding treatment effects.
Laminar fMRI can non-invasively resolve cortical layer activity, bridging nano- and macro-scale mechanisms to improve epilepsy insights.
Guideline-Based Recommendations
Diagnosis
Use macro-scale modalities such as EEG, PET, MRI, and conventional fMRI to identify seizure networks.
Consider emerging laminar fMRI techniques to assess layer-specific cortical activity related to seizure generation.
Management
Antiseizure medications remain first-line treatment but are often empirically applied due to limited mechanistic mapping.
Laminar fMRI may enhance surgical targeting in focal epilepsy by identifying ictogenic microcircuits.
Future therapies should aim to integrate multi-scale understanding from nano- to macro-levels.
Monitoring & Follow-up
Monitor seizure activity and treatment response primarily via EEG and macro-scale imaging.
Research use of laminar fMRI to track microcircuit-level changes during treatment.
Risks
Variable response to antiseizure medications due to incomplete understanding of multi-scale mechanisms.
Surgical failure in drug-resistant focal epilepsy may result from inadequate targeting of microcircuit dysfunction.
Patient & Prescribing Data
Patients with epilepsy, including those with drug-resistant forms
Antiseizure medications target nano-scale ion channels and receptors but clinical effects are measured at macro-scale, leading to empirical treatment approaches and variable efficacy.
Clinical Best Practices
Recognize epilepsy as a multi-scale disorder requiring integration of nano-, micro-, and macro-scale data.
Incorporate advanced imaging techniques like laminar fMRI to better understand seizure microcircuitry.
Use laminar fMRI findings to potentially improve surgical planning and personalize antiseizure medication strategies.
Continue reliance on established macro-scale diagnostic tools while supporting research into microcircuit-level assessments.
